Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer Cells

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2015
Eligible patients will recieve apatinib treatment(500mg qd p.o. q28d) for 6 cycles after 8 cycles of XELOX adjuvant chemotherapy or only XELOX adjuvant chemotherapy.
Epistemonikos ID: 2982b07ce1b60c207d6bade502f70dabee359d8a
First added on: May 12, 2024